Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomic signatures of loss of glycemic control in youth-onset type 2 diabetes in the TODAY study.

The Journal of clinical endocrinology and metabolism·2026
Same author

Prevalence of a Composite Outcome to Capture Child and Liver Health One Year After Pediatric Liver Transplantation in the Starzl Network.

Pediatric transplantation·2026
Same author

Revisiting POWER in the GLP-1 Age.

Gastroenterology·2026
Same author

A 10-Year Cost-Effectiveness Analysis of Metabolic and Bariatric Surgery in Adolescents.

JAMA network open·2026
Same author

The incidence, frequency of late liver-related complications, and transplant likelihood in pediatric acute liver failure in Californian children.

Hepatology communications·2026
Same author

Supporting Safer Surgery: System-Level Interventions to Enhance Pediatric Perioperative Safety.

Pediatrics·2026

Related Experiment Video

Updated: Jun 4, 2026

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

Molecular insights from bariatric surgery.

Rohit Kohli1, Margaret A Stefater, Thomas H Inge

  • 1Division of Gastroenterology, Hepatology, and Nutrition, MLC 2010, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, OH 45229, USA. rohit.kohli@cchmc.org

Reviews in Endocrine & Metabolic Disorders
|February 19, 2011
PubMed
Summary

Bariatric surgery effectively treats obesity and its related conditions like type 2 diabetes (T2DM). This review explores how these procedures offer metabolic benefits independent of weight loss, revealing crucial molecular changes.

More Related Videos

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Related Experiment Videos

Last Updated: Jun 4, 2026

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

Sleeve Gastrectomy in Mice using Surgical Clips
05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
08:50

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Area of Science:

  • Metabolic surgery
  • Obesity medicine
  • Endocrinology

Background:

  • Bariatric surgery is a key treatment for morbid obesity and associated comorbidities like type 2 diabetes (T2DM), metabolic syndrome, and cardiovascular disease.
  • Procedures such as Roux-en-Y gastric bypass (RYGB), gastric banding (GB), and vertical sleeve gastrectomy (VSG) effectively reduce weight and improve obesity-related conditions.
  • However, bariatric surgery carries risks, and the rapid improvement in T2DM preceding weight loss suggests weight-loss-independent mechanisms are at play.

Purpose of the Study:

  • To review the molecular changes across biological systems following bariatric surgery.
  • To discuss the weight-loss-independent metabolic benefits of bariatric procedures, including improved insulin sensitivity.
  • To explore the central nervous system integration of signals related to these metabolic improvements.

Main Methods:

  • Literature review of molecular changes after bariatric surgery.
  • Analysis of hepatic, adipocyte, and gut-derived signals.
  • Examination of studies on weight-loss-independent metabolic improvements and insulin sensitivity.

Main Results:

  • Bariatric surgery induces significant molecular alterations in various tissues.
  • Changes in hepatic, adipocyte, and gut signaling contribute to metabolic improvements.
  • Evidence suggests improvements in insulin sensitivity and central nervous system regulation occur independently of substantial weight loss.

Conclusions:

  • Understanding the molecular mechanisms behind weight-loss-independent benefits is crucial for developing novel obesity therapeutics.
  • Bariatric surgery offers insights into metabolic regulation beyond simple weight reduction.
  • Further research into these pathways could lead to more effective and accessible obesity treatments.